Status: Recruiting
A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
The purpose of this clinical trial is to assess the efficacy and safety of HTMC0658 tablets in treating subjects with chronic rhinosinusitis without nasal polyps (CRSsNP).
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.Updated: Sep 19, 2025Locations: 1
Eligibility criteria
Subjects aged between 18 and 75 years, inclusive, of either sex. [+10]
Presence of nasal polyps confirmed by nasal endoscopy during the screening perio... [+20]